New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) will be conducting a review of ...

Researchers report the 5-year survival outcomes with lisocabtagene maraleucel in heavily pretreated patients with relapsed or ...

In patients with ulcerative colitis exposed to anti-TNF therapy, tofacitinib is linked to higher rates of clinical and ...

Fear, withdrawal symptoms, and a lack of professional support are common barriers to detoxification from opioid substitution ...

Supplementation with vitamin K2 may help slow the progression of coronary artery calcification among people with mild ...

Qure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of ...

The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.

The EMA says the benefits of Tavneos no longer outweigh the risks for the treatment of active granulomatosis with polyangiitis.

Home-based human papillomavirus screening for cervical cancer shows modest uptake in a diverse community setting.

A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.